These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30181547)

  • 1. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
    Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson IL; Juhlin CC; Larsson C; Xu D
    Oncogene; 2019 Feb; 38(7):965-979. PubMed ID: 30181547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
    Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
    Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.
    Yuan X; Dai M; Xu D
    Cancer Lett; 2020 Nov; 493():1-9. PubMed ID: 32768523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
    Guo Y; Yuan X; Li K; Dai M; Zhang L; Wu Y; Sun C; Chen Y; Cheng G; Liu C; Strååt K; Kong F; Zhao S; Bjorkhölm M; Xu D
    Cell Death Differ; 2020 Jun; 27(6):1862-1877. PubMed ID: 31802036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
    Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
    Bu R; Siraj AK; Divya SP; Kong Y; Parvathareddy SK; Al-Rasheed M; Al-Obaisi KAS; Victoria IG; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
    Int J Cancer; 2018 May; 142(10):2028-2039. PubMed ID: 29266240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours.
    Paulsson JO; Wang N; Gao J; Stenman A; Zedenius J; Mu N; Lui WO; Larsson C; Juhlin CC
    Endocr Relat Cancer; 2020 May; 27(5):295-308. PubMed ID: 32163919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Dosage-Dependent Role of
    Rojo-Pardillo M; Godefroid L; Dom G; Lefort A; Libert F; Robaye B; Maenhaut C
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
    Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
    Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors.
    Minna E; Devecchi A; Pistore F; Paolini B; Mauro G; Penso DA; Pagliardini S; Busico A; Pruneri G; De Cecco L; Borrello MG; Sensi M; Greco A
    Front Endocrinol (Lausanne); 2023; 14():1267499. PubMed ID: 37867524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Positive Feedback Loop Between DICER1 and Differentiation Transcription Factors Is Important for Thyroid Tumorigenesis.
    Ramírez-Moya J; Santisteban P
    Thyroid; 2021 Jun; 31(6):912-921. PubMed ID: 33176626
    [No Abstract]   [Full Text] [Related]  

  • 13. TERT Promoter Mutations Increase Tumor Aggressiveness by Altering TERT mRNA Splicing in Papillary Thyroid Carcinoma.
    Sako A; Matsuse M; Saenko V; Tanaka A; Otsubo R; Morita M; Kuba S; Nishihara E; Suzuki K; Ogi T; Kawakami A; Mitsutake N
    J Clin Endocrinol Metab; 2024 Sep; 109(10):e1827-e1838. PubMed ID: 38576411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
    McKelvey BA; Gilpatrick T; Wang Y; Timp W; Umbricht CB; Zeiger MA
    Thyroid; 2020 Oct; 30(10):1470-1481. PubMed ID: 32228178
    [No Abstract]   [Full Text] [Related]  

  • 15. Predominant
    Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
    Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
    [No Abstract]   [Full Text] [Related]  

  • 16. GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma.
    Fang Z; Zhang N; Yuan X; Xing X; Li X; Qin X; Liu Z; Neo S; Liu C; Kong F; Björkholm M; Fan Y; Xu D
    J Exp Clin Cancer Res; 2022 May; 41(1):173. PubMed ID: 35549739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma.
    Wasserman JD; Sabbaghian N; Fahiminiya S; Chami R; Mete O; Acker M; Wu MK; Shlien A; de Kock L; Foulkes WD
    J Clin Endocrinol Metab; 2018 May; 103(5):2009-2015. PubMed ID: 29474644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DICER1 mutated, solid/trabecular thyroid papillary carcinoma in an 11-year-old child].
    Ravella L; Lopez J; Descotes F; Lifante JC; David C; Decaussin-Petrucci M
    Ann Pathol; 2018 Oct; 38(5):316-320. PubMed ID: 29884466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.
    Trybek T; Walczyk A; Gąsior-Perczak D; Pałyga I; Mikina E; Kowalik A; Hińcza K; Kopczyński J; Chrapek M; Góźdź S; Kowalska A
    Endocrinology; 2019 Oct; 160(10):2328-2338. PubMed ID: 31305897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
    Avin BA; Wang Y; Gilpatrick T; Workman RE; Lee I; Timp W; Umbricht CB; Zeiger MA
    Genes Chromosomes Cancer; 2019 Aug; 58(8):530-540. PubMed ID: 30664813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.